[On Demand]
BioStrand offers a revolutionary methodology for identifying similarities and variations in omics data and detecting structural anchor points that will drive innovation in precision medicine, drug development and agriculture. The BioStrand methodology enables unprecedented scalability, speed and accuracy in detecting similarities and variations in DNA, RNA and proteins. Not only do we integrate all layers of omic data (DNA, RNA and AA) in one knowledge base, we also integrate the whole data analysis process into one workflow spanning from raw sequence data processing to interpretation.

By detecting HYFTS™, structural 3D information is automatically integrated into the analyses, revolutionising pattern and profile detection that is critical in unraveling diseases and biological processes. Because we combine sequence and structure analysis, BioStrand AI discovery opens up whole new possibilities in prediction of protein-protein interaction and de novo structure prediction of proteins
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Retrieve and Relate
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided